Pyxis Oncology, Inc. - Common Stock (NQ:PYXS)

1.690 +0.010 (+0.60%)

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pyxis Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update

November 07, 2023

From Pyxis Oncology

Via GlobeNewswire

New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review

October 13, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:PYXS),(NASDAQ:AZN),(NYSE:LLY),(NASDAQ:MRUS) EQNX::TICKER_END

Via FinancialNewsMedia

NASDAQ:PYXS Investor Notice: Investigation over Possible Securities Laws Violations by Pyxis Oncology, Inc. ↗

October 05, 2023

San Diego, CA -- (SBWIRE) -- 10/05/2023 -- Pyxis Oncology, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023

September 27, 2023

From Pyxis Oncology

Via GlobeNewswire

Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst ↗

September 05, 2023

RBC Capital Markets has initiated coverage on Pyxis Oncology Inc (NASDAQ: PYXS) with an Outperform rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗

September 05, 2023

Via Benzinga

Pyxis Oncology to Participate in Two Upcoming Investment Conferences

August 31, 2023

From Pyxis Oncology

Via GlobeNewswire

Pyxis Oncology Successfully Completes Acquisition of Apexigen

August 23, 2023

From Pyxis Oncology

Via GlobeNewswire

Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update

August 11, 2023

From Pyxis Oncology

Via GlobeNewswire

Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference

August 01, 2023

From Pyxis Oncology

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗

July 31, 2023

Via Benzinga

Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M ↗

May 24, 2023

Via Benzinga

Pyxis Oncology Bolsters Oncology Portfolio Through $16M Apexigen Acquisition ↗

May 24, 2023

Pyxis Oncology (NASDAQ:PYXS) has announced an acquisition of Apexigen (NASDAQ:APGN) that is expected to be completed in the second half of 2023.

Via Benzinga

Why Is Apexigen (APGN) Stock Up 31% Today? ↗

May 24, 2023

Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS).

Via InvestorPlace

Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗

April 05, 2023

Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.

Via Benzinga

Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 04, 2023

Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 31, 2023

Via Benzinga

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 31, 2023

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.

Via Benzinga

Top 5 Health Care Stocks That May Collapse ↗

March 31, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 30, 2023

Via Benzinga

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 28, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 27, 2023

Via Benzinga

Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 27, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.

Via Benzinga

US Stocks Open Higher; Dow Rises 200 Points ↗

March 27, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.64% to 32,443.64 while the NASDAQ rose 0.20% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 27, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 24, 2023

It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!

Via InvestorPlace

Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket ↗

March 22, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 22, 2023

The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning!

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.